The RUNX complex: Reaching beyond haematopoiesis into immunity

Immunology

Volumn 146, Issue 4, 2015, Pages 523-536

  Voon, Dominic Chih Cheng ^a   Hor, Yit Teng ^b   Ito, Yoshiaki ^c  

^a KANAZAWA UNIVERSITY   (Japan)

^b CANCER RESEARCH MALAYSIA   (Malaysia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Autoimmunity; Haematopoiesis; Immune system; Mucosal immunity; RUNX transcription factors

Indexed keywords

TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL FATE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNITY; INFLAMMATORY DISEASE; INNATE IMMUNITY; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; ANIMAL; BONE MARROW CELL; CYTOLOGY; EMBRYOLOGY; GENETICS; IMMUNOLOGY; INFLAMMATION; LYMPHOID TISSUE; METABOLISM; MULTIGENE FAMILY; ORGANOGENESIS;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA SUBUNITS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNITY; IMMUNITY, MUCOSAL; INFLAMMATION; LYMPHOID TISSUE; MULTIGENE FAMILY; MYELOID CELLS; ORGANOGENESIS; T-LYMPHOCYTE SUBSETS; THYMOCYTES; TRANSCRIPTION FACTORS;

EID: 84983200707     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12535     Document Type: Article

References (132)

1. Ito Y, Bae SC, Chuang LS. The RUNX family: developmental regulators in cancer. Nat Rev Cancer 2015; 15:81-95.
2. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84:321-30.
3. Dzierzak E, Speck NA. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat Immunol 2008; 9:129-36.
4. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010; 339:189-95.
5. de Bruijn MF, Speck NA. Core-binding factors in hematopoiesis and immune function. Oncogene 2004; 23:4238-48.
6. Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, Satake M et al. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol 1990; 64:4808-19.
7. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 1996; 93:3444-9.
8. North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 1999; 126:2563-75.
9. Yokomizo T, Ogawa M, Osato M, Kanno T, Yoshida H, Fujimoto T et al. Requirement of Runx1/AML1/PEBP2αB for the generation of haematopoietic cells from endothelial cells. Genes Cells 2001; 6:13-23.
10. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009; 457:887-91.
11. Kissa K, Herbomel P. Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 2010; 464:112-5.
12. Chen MJ, Li Y, De Obaldia ME, Yang Q, Yzaguirre AD, Yamada-Inagawa T et al. Erythroid/myeloid progenitors and hematopoietic stem cells originate from distinct populations of endothelial cells. Cell Stem Cell 2011; 9:541-52.
13. Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, Yamagata T et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 2004; 10:299-304.
14. Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, Rowan R et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005; 106:494-504.
15. Putz G, Rosner A, Nuesslein I, Schmitz N, Buchholz F. AML1 deletion in adult mice causes splenomegaly and lymphomas. Oncogene 2006; 25:929-39.
16. Motoda L, Osato M, Yamashita N, Jacob B, Chen LQ, Yanagida M et al. Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult. Stem Cells 2007; 25:2976-86.
17. Jacob B, Osato M, Yamashita N, Wang CQ, Taniuchi I, Littman DR et al. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood 2010; 115:1610-20.
18. Wang CQ, Jacob B, Nah GS, Osato M. Runx family genes, niche, and stem cell quiescence. Blood Cells Mol Dis 2010; 44:275-86.
19. Wang CQ, Krishnan V, Tay LS, Chin DW, Koh CP, Chooi JY et al. Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects. Cell Rep 2014; 8:767-82.
20. + dendritic cell progenitors and restrict myeloproliferative disorder. Blood 2014; 123:2968-77.
21. Wang CQ, Chin DW, Chooi JY, Chng WJ, Taniuchi I, Tergaonkar V et al. Cbfb deficiency results in differentiation blocks and stem/progenitor cell expansion in hematopoiesis. Leukemia 2015; 29:753-7.
22. Collins A, Littman DR, Taniuchi I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat Rev Immunol 2009; 9:106-15.
23. Satake M, Nomura S, Yamaguchi-Iwai Y, Takahama Y, Hashimoto Y, Niki M et al. Expression of the Runt domain-encoding PEBP2 α genes in T cells during thymic development. Mol Cell Biol 1995; 15:1662-70.
24. Levanon D, Bernstein Y, Negreanu V, Ghozi MC, Bar-Am I, Aloya R et al. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol 1996; 15:175-85.
25. North TE, Stacy T, Matheny CJ, Speck NA, de Bruijn MF. Runx1 is expressed in adult mouse hematopoietic stem cells and differentiating myeloid and lymphoid cells, but not in maturing erythroid cells. Stem Cells 2004; 22:158-68.
26. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002; 111:621-33.
27. Lorsbach RB, Moore J, Ang SO, Sun W, Lenny N, Downing JR. Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. Blood 2004; 103:2522-9.
28. Hernandez-Munain C, Krangel MS. Regulation of the T-cell receptor δ enhancer by functional cooperation between c-Myb and core-binding factors. Mol Cell Biol 1994; 14:473-83.
29. Lauzurica P, Zhong XP, Krangel MS, Roberts JL. Regulation of T cell receptor δ gene rearrangement by CBF/PEBP2. J Exp Med 1997; 185:1193-201.
30. Wotton D, Ghysdael J, Wang S, Speck NA, Owen MJ. Cooperative binding of Ets-1 and core binding factor to DNA. Mol Cell Biol 1994; 14:840-50.
31. Giese K, Kingsley C, Kirshner JR, Grosschedl R. Assembly and function of a TCR α enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 1995; 9:995-1008.
32. Cieslak A, Le Noir S, Trinquand A, Lhermitte L, Franchini DM, Villarese P et al. RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement. J Exp Med 2014; 211:1821-32.
33. Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 2008; 319:822-5.
34. + T cells. Nat Immunol 2014; 15:646-56.
35. Collins A, Hewitt SL, Chaumeil J, Sellars M, Micsinai M, Allinne J et al. RUNX transcription factor-mediated association of Cd4 and Cd8 enables coordinate gene regulation. Immunity 2011; 34:303-14.
36. Djuretic IM, Cruz-Guilloty F, Rao A. Regulation of gene expression in peripheral T cells by Runx transcription factors. Adv Immunol 2009; 104:1-23.
37. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 2007; 8:145-53.
38. Naoe Y, Setoguchi R, Akiyama K, Muroi S, Kuroda M, Hatam F et al. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf β binding to the Il4 silencer. J Exp Med 2007; 204:1749-55.
39. Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, Lichtenheld MG et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med 2009; 206:51-9.
40. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-87.
41. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-8.
42. + regulatory T cells. Immunity 2009; 31:609-20.
43. Rudra D, Egawa T, Chong MM, Treuting P, Littman DR, Rudensky AY. Runx-CBFβ complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat Immunol 2009; 10:1170-7.
44. + inducible regulatory T cells. J Exp Med 2009; 206:2701-15.
45. Bruno L, Mazzarella L, Hoogenkamp M, Hertweck A, Cobb BS, Sauer S et al. Runx proteins regulate Foxp3 expression. J Exp Med 2009; 206:2329-37.
46. Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, Nomura T et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007; 446:685-9.
47. Brenner O, Levanon D, Negreanu V, Golubkov O, Fainaru O, Woolf E et al. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc Natl Acad Sci USA 2004; 101:16016-21.
48. Fainaru O, Shseyov D, Hantisteanu S, Groner Y. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc Natl Acad Sci USA 2005; 102:10598-603.
49. Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007; 19:409-17.
50. H17 lineage. Nature 2006; 441:231-4.
51. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-89.
52. Singh RP, Hasan S, Sharma S, Nagra S, Yamaguchi DT, Wong DT et al. Th17 cells in inflammation and autoimmunity. Autoimmun Rev 2014; 13:1174-81.
53. Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S et al. Requirement for RORγ in thymocyte survival and lymphoid organ development. Science 2000; 288:2369-73.
54. + T helper cells. Cell 2006; 126:1121-33.
55. Zhang F, Meng G, Strober W. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol 2008; 9:1297-306.
56. Ramesh R, Kozhaya L, McKevitt K, Djuretic IM, Carlson TJ, Quintero MA et al. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med 2014; 211:89-104.
57. Wang Y, Godec J, Ben-Aissa K, Cui K, Zhao K, Pucsek AB et al. The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells. Immunity 2014; 40:355-66.
58. Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, Awasthi A et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 2013; 496:461-8.
59. Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013; 496:513-7.
60. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496:518-22.
61. +CD8αα intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses. J Immunol 2007; 178:4230-9.
62. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256-60.
63. Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 2011; 11:445-56.
64. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L et al. Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol 2012; 13:569-78.
65. + T cell immunity. Nat Immunol 2013; 14:271-80.
66. + intraepithelial lymphocyte development. Immunity 2014; 41:230-43.
67. Reis BS, Hoytema van Konijnenburg DP, Grivennikov SI, Mucida D. Transcription factor T-bet regulates intraepithelial lymphocyte functional maturation. Immunity 2014; 41:244-56.
68. Egawa T, Littman DR. ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat Immunol 2008; 9:1131-9.
69. Woolf E, Xiao C, Fainaru O, Lotem J, Rosen D, Negreanu V et al. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc Natl Acad Sci USA 2003; 100:7731-6.
70. Monteiro M, Graca L. iNKT cells: innate lymphocytes with a diverse response. Crit Rev Immunol 2014; 34:81-90.
71. Egawa T, Eberl G, Taniuchi I, Benlagha K, Geissmann F, Hennighausen L et al. Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 2005; 22:705-16.
72. Tachibana M, Tenno M, Tezuka C, Sugiyama M, Yoshida H, Taniuchi I. Runx1/Cbfβ2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages. J Immunol 2011; 186:1450-7.
73. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A et al. Overexpression of natural killer T cells protects Vα14- Jα281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998; 188:1831-9.
74. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336:489-93.
75. Woolf E, Brenner O, Goldenberg D, Levanon D, Groner Y. Runx3 regulates dendritic epidermal T cell development. Dev Biol 2007; 303:703-14.
76. + T cells. J Immunol 2005; 175:1694-705.
77. Sharp LL, Jameson JM, Witherden DA, Komori HK, Havran WL. Dendritic epidermal T-cell activation. Crit Rev Immunol 2005; 25:1-18.
78. Shi MJ, Stavnezer J. CBF α3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter. J Immunol 1998; 161:6751-60.
79. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J Biol Chem 1999; 274:31577-82.
80. Pardali E, Xie XQ, Tsapogas P, Itoh S, Arvanitidis K, Heldin CH et al. Smad and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germ-line IgA genes. J Biol Chem 2000; 275:3552-60.
81. Zhang Y, Derynck R. Transcriptional regulation of the transforming growth factor-β -inducible mouse germ line Ig α constant region gene by functional cooperation of Smad, CREB, and AML family members. J Biol Chem 2000; 275:16979-85.
82. Watanabe K, Sugai M, Nambu Y, Osato M, Hayashi T, Kawaguchi M et al. Requirement for Runx proteins in IgA class switching acting downstream of TGF-β1 and retinoic acid signaling. J Immunol 2010; 184:2785-92.
83. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Goldenberg D et al. Runx3 regulates mouse TGF-β-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 2004; 23:969-79.
84. Maier H, Ostraat R, Gao H, Fields S, Shinton SA, Medina KL et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol 2004; 5:1069-77.
85. Seo W, Ikawa T, Kawamoto H, Taniuchi I. Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1. J Exp Med 2012; 209:1255-62.
86. Martensson A, Xie XQ, Persson C, Holm M, Grundstrom T, Martensson IL. PEBP2 and c-myb sites crucial for λ5 core enhancer activity in pre-B cells. Eur J Immunol 2001; 31:3165-74.
87. Cerutti A. The regulation of IgA class switching. Nat Rev Immunol 2008; 8:421-34.
88. Spender LC, Cornish GH, Sullivan A, Farrell PJ. Expression of transcription factor AML-2 (RUNX3, CBFα-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J Virol 2002; 76:4919-27.
89. Spender LC, Whiteman HJ, Karstegl CE, Farrell PJ. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene 2005; 24:1873-81.
90. Brady G, Elgueta Karstegl C, Farrell PJ. Novel function of the unique N-terminal region of RUNX1c in B cell growth regulation. Nucleic Acids Res 2013; 41:1555-68.
91. Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J et al. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci USA 2011; 108:14902-7.
92. Brady G, Whiteman HJ, Spender LC, Farrell PJ. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation. J Virol 2009; 83:6909-16.
93. Jiang S, Willox B, Zhou H, Holthaus AM, Wang A, Shi TT et al. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc Natl Acad Sci USA 2014; 111:421-6.
94. O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004; 199:91-8.
95. Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, Cooper MD. Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med 2008; 205:1807-17.
96. Whiteman HJ, Farrell PJ. RUNX expression and function in human B cells. Crit Rev Eukaryot Gene Expr 2006; 16:31-44.
97. Withers DR. Lymphoid tissue inducer cells. Curr Biol 2011; 21:R381-2.
98. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9:503-10.
99. Martinet L, Smyth MJ. Balancing natural killer cell activation through paired receptors. Nat Rev Immunol 2015; 15:243-54.
100. Talebian L, Li Z, Guo Y, Gaudet J, Speck ME, Sugiyama D et al. T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFβ dosage. Blood 2007; 109:11-21.
101. Guo Y, Maillard I, Chakraborti S, Rothenberg EV, Speck NA. Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification. Blood 2008; 112:480-92.
102. Ohno S, Sato T, Kohu K, Takeda K, Okumura K, Satake M et al. Runx proteins are involved in regulation of CD122, Ly49 family and IFN-γ expression during NK cell differentiation. Int Immunol 2008; 20:71-9.
103. Hayashi K, Natsume W, Watanabe T, Abe N, Iwai N, Okada H et al. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells. J Immunol 2000; 165:6816-24.
104. Levanon D, Negreanu V, Lotem J, Bone KR, Brenner O, Leshkowitz D et al. Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation. Mol Cell Biol 2014; 34:1158-69.
105. Chopin M, Seillet C, Chevrier S, Wu L, Wang H, Morse HC 3rd et al. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J Exp Med 2013; 210:2967-80.
106. Puig-Kroger A, Aguilera-Montilla N, Martinez-Nunez R, Dominguez-Soto A, Sanchez-Cabo F, Martin-Gayo E et al. The novel RUNX3/p33 isoform is induced upon monocyte-derived dendritic cell maturation and downregulates IL-8 expression. Immunobiology 2010; 215:812-20.
107. Mukai K, BenBarak MJ, Tachibana M, Nishida K, Karasuyama H, Taniuchi I et al. Critical role of P1-Runx1 in mouse basophil development. Blood 2012; 120:76-85.
108. Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM et al. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol 1996; 16:1231-40.
109. Himes SR, Cronau S, Mulford C, Hume DA. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages. Oncogene 2005; 24:5278-86.
110. Dominguez-Soto A, Relloso M, Vega MA, Corbi AL, Puig-Kroger A. RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters. Immunobiology 2005; 210:133-9.
111. Estecha A, Aguilera-Montilla N, Sanchez-Mateos P, Puig-Kroger A. RUNX3 regulates intercellular adhesion molecule 3 (ICAM-3) expression during macrophage differentiation and monocyte extravasation. PLoS ONE 2012; 7:e33313.
112. Puig-Kroger A, Sanchez-Elsner T, Ruiz N, Andreu EJ, Prosper F, Jensen UB et al. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood 2003; 102:3252-61.
113. Alliot F, Godin I, Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 1999; 117:145-52.
114. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010; 330:841-5.
115. Zusso M, Methot L, Lo R, Greenhalgh AD, David S, Stifani S. Regulation of postnatal forebrain amoeboid microglial cell proliferation and development by the transcription factor Runx1. J Neurosci 2012; 32:11285-98.
116. Bowcock AM. The genetics of psoriasis and autoimmunity. Annu Rev Genomics Hum Genet 2005; 6:93-122.
117. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32:666-9.
118. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366:2443-54.
119. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 2003; 35:349-56.
120. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003; 35:341-8.
121. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 1998; 95:7502-7.
122. Cho JH, Nicolae DL, Ramos R, Fields CT, Rabenau K, Corradino S et al. Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum Mol Genet 2000; 9:1425-32.
123. Parkes M, Jewell D. Ulcerative colitis and Crohns disease: molecular genetics and clinical implications. Expert Rev Mol Med 2001; 2001:1-18.
124. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010; 42:295-302.
125. Weersma RK, Zhou L, Nolte IM, van der Steege G, van Dullemen HM, Oosterom E et al. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Inflamm Bowel Dis 2008; 14:1615-22.
126. Haley KJ, Lasky-Su J, Manoli SE, Smith LA, Shahsafaei A, Weiss ST et al. RUNX transcription factors: association with pediatric asthma and modulated by maternal smoking. Am J Physiol Lung Cell Mol Physiol 2011; 301:L693-701.
127. Taniuchi I. Transcriptional regulation in helper versus cytotoxic-lineage decision. Curr Opin Immunol 2009; 21:127-32.
128. Cerutti A, Puga I, Cols M. Innate control of B cell responses. Trends Immunol 2011; 32:202-11.
129. Hor YT, Voon DC, Koo JK, Wang H, Lau WM, Ashktorab H et al. A role for RUNX3 in inflammation-induced expression of IL23A in gastric epithelial cells. Cell Rep 2014; 8:50-8.
130. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233-40.
131. Venkatesh B, Lee AP, Ravi V, Maurya AK, Lian MM, Swann JB et al. Elephant shark genome provides unique insights into gnathostome evolution. Nature 2014; 505:174-9.
132. Egawa T, Tillman RE, Naoe Y, Taniuchi I, Littman DR. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J Exp Med 2007; 204:1945-57.